LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.19, Iss.3, 2000-03, pp. : 219-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid oxidation products and atherosclerosis

By Berliner J.

General Pharmacology, Vol. 38, Iss. 4, 2002-04 ,pp. : 187-191

Elsevier

Access to resources Recommend Favorite

Lipid pharmacotherapy for treatment of atherosclerosis

By Nicholls Stephen J Pisaniello Anthony D Kataoka Yu Puri Rishi

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 8, 2014-06 ,pp. : 1119-1125

Informa Healthcare

Access to resources Recommend Favorite

Cost of Treating to a Modified European Atherosclerosis Society LDL-C Target: Comparison of Atorvastatin with Fluvastatin, Pravastatin and Simvastatin

By Smith D.G.

Clinical Drug Investigation, Vol. 17, Iss. 3, 1999-03 ,pp. : 185-193

Adis International

Access to resources Recommend Favorite

Lipid Lowering Agents, Inflammation and Atherosclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 7, Iss. 3, 2008-09 ,pp. : 206-216

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary: The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study

By Paragh György

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 647-660

Adis International

Access to resources Recommend Favorite